SGAM
COLL icon

Smith Group Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Smith Group Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.68M Buy
73,896
+51,945
+237% +$1.78M 0.11% 60
2026
Q1 		$726K Buy
21,951
+1,865
+9% +$79K 0.04% 109
2025
Q4 		$930K Buy
20,086
+498
+3% +$20.8K 0.05% 101
2025
Q3 		$685K Buy
19,588
+576
+3% +$20K 0.04% 114
2025
Q2 		$562K Sell
19,012
-73
-0.4% -$2.08K 0.04% 122
2025
Q1 		$570K Buy
19,085
+73
+0.4% +$2.23K 0.04% 123
2024
Q4 		$545K Buy
19,012
+188
+1% +$6.22K 0.04% 136
2024
Q3 		$727K Buy
18,824
+3,774
+25% +$135K 0.06% 76
2024
Q2 		$485K Buy
15,050
+90
+0.6% +$3.12K 0.04% 84
2024
Q1 		$581K Hold
14,960
– – 0.03% 129
2023
Q4 		$460K Buy
+14,960
New +$375K 0.03% 133
2022
Q1 		$241K Sell
11,815
-8,487
-42% -$160K 0.01% 157
2021
Q4 		$379K Sell
20,302
-524
-3% -$10.2K 0.02% 153
2021
Q3 		$411K Sell
20,826
-334
-2% -$7.22K 0.02% 144
2021
Q2 		$500K Sell
21,160
-205
-1% -$4.74K 0.02% 135
2021
Q1 		$506K Hold
21,365
– – 0.03% 131
2020
Q4 		$428K Sell
21,365
-6,970
-25% -$136K 0.02% 145
2020
Q3 		$590K Sell
28,335
-3,420
-11% -$61.7K 0.03% 121
2020
Q2 		$556K Sell
31,755
-19,758
-38% -$387K 0.03% 127
2020
Q1 		$841K Buy
51,513
+35,883
+230% +$741K 0.05% 98
2019
Q4 		$322K Hold
15,630
– – 0.01% 164
2019
Q3 		$179K Buy
+15,630
New +$178K 0.01% 198

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Smith Group Asset Management's COLL Position: Q2 2026 in Review

Smith Group Asset Management increased its Collegium Pharmaceutical (COLL) stake by 237% in Q2 2026, buying an estimated $1.78M and bringing the position to 73,896 shares worth $2.68M. The position accounts for 0.11% of the portfolio, ranked #60.

Smith Group Asset Management first reported a position in COLL in Q3 2019 and has held it in 22 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Smith Group Asset Management held 73,896 shares of Collegium Pharmaceutical worth $2.68M as of Q2 2026.
  • Smith Group Asset Management bought 51,945 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.78M.
  • Collegium Pharmaceutical made up 0.11% of Smith Group Asset Management's portfolio in Q2 2026, its #60 holding.
  • Smith Group Asset Management first reported a position in Collegium Pharmaceutical in Q3 2019 and has held it in 22 quarters since.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Smith Group Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.